Ledger.Open graph →
SEC Form D · filed August 8, 2014

VBI VACCINES INC

Offering
$36.4M
Sold
$36.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Michel A. Dewilde · Cambridge, MADirectorDavid Anderson · Cambridge, MAExecTrent A. Davis · Cambridge, MADirectorEgidio Nascimento · Cambridge, MAExecSteve A. Gillis · Cambridge, MADirectorJeff Baxter · Cambridge, MAExec · DirectorAlan A. Timmins · Cambridge, MADirectorMichael A. Steinmetz · Cambridge, MADirectorMarc A. Kirchmeier · Cambridge, MAExecT. A. Buckley · Cambridge, MAExecSam A. Chawla · Cambridge, MADirectorJonathan Taylor · Salt Lake City, UTExecTeraForm Ventures Iv LLC · Salt Lake City, UTExec · DirectorElliott Smith · Salt Lake City, UTExecJason Smith · Salt Lake City, UTDirectorVirginia C. Yee · San Francisco, CAExecEdward C. Callaway · San Francisco, CADirectorArsani H. William · San Francisco, CADirectorEdward H. Zhong · San Francisco, CADirectorYanni H. Souroutzidis · San Francisco, CAExecGraham H. Walmsley · San Francisco, CADirectorJeffrey Howard · NORTHBROOK, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗